Innoviva (INVA) Asset Utilization Ratio (2011 - 2026)

Innoviva (INVA) posted Asset Utilization Ratio of 0.29 for Q1 2026, down 10.04% on a QoQ basis from 0.32 in Q4 2025, and down 20.04% year-over-year from 0.36 in Q1 2025.

Innoviva (INVA) Asset Utilization Ratio (2011 - 2026) Analysis & Trends

Innoviva's Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.29 for Q1 2026.

  • Quarterly Asset Utilization Ratio fell 20.04% year-over-year to 0.29 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.29 (down 20.04% YoY) and the FY2025 annual result came in at 0.27, down 5.22% from the prior year.
  • Asset Utilization Ratio was 0.29 for Q1 2026 at Innoviva, down from 0.32 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.36 in Q1 2025 and bottomed at 0.18 in Q1 2024.
  • A 5-year average of 0.27 and a median of 0.26 in 2024 frame the typical range for Asset Utilization Ratio.
  • Peak annual rise in Asset Utilization Ratio reached 160.7% in 2022, while the deepest fall reached 35.8% in 2022.
  • Innoviva's Asset Utilization Ratio stood at 0.21 in 2022, then slipped by 10.99% to 0.19 in 2023, then soared by 54.12% to 0.29 in 2024, then increased by 8.57% to 0.32 in 2025, then decreased by 10.04% to 0.29 in 2026.
  • Business Quant data shows INVA's Asset Utilization Ratio at 0.29 in Q1 2026, 0.32 in Q4 2025, and 0.35 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 0.69
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.47
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.37
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn 0.29

Historic Data

Download Data
DateValue
Mar 31, 2026 0.29
Dec 31, 2025 0.32
Sep 30, 2025 0.35
Jun 30, 2025 0.35
Mar 31, 2025 0.36
Dec 31, 2024 0.29
Sep 30, 2024 0.30
Jun 30, 2024 0.26
Mar 31, 2024 0.18
Dec 31, 2023 0.19
Sep 30, 2023 0.20
Jun 30, 2023 0.24
Mar 31, 2023 0.23
Dec 31, 2022 0.21
Sep 30, 2022 0.22
Jun 30, 2022 0.26
Mar 31, 2022 0.29
Dec 31, 2021 0.32
Sep 30, 2021 0.34
Jun 30, 2021 0.10